Rocket Pharmaceuticals (RCKT) Long-Term Debt Issuances (2014 - 2016)
Rocket Pharmaceuticals (RCKT) posted Long-Term Debt Issuances of -$52.0 million for Q4 2016, down 442.01% sequentially from $15.2 million in Q4 2015, and down 442.01% YoY from $15.2 million in Q1 2016.
Rocket Pharmaceuticals (RCKT) Long-Term Debt Issuances (2014 - 2016) Analysis & Trends
Rocket Pharmaceuticals has reported Long-Term Debt Issuances for 3 years, with the latest figure at -$52.0 million in Q4 2016.
- Quarterly Long-Term Debt Issuances fell 442.01% year-over-year to -$52.0 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was -$52.0 million (down 347.55% YoY) and the FY2016 annual result came in at $14000.0, down 99.93% from the prior year.
- Long-Term Debt Issuances fell to -$52.0 million in Q4 2016 per RCKT's latest filing, from $15.2 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $21.0 million in Q1 2015 and troughed at -$52.0 million in Q4 2016.
- A 3-year average of -$6.1 million and a median of $715000.0 in 2014 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2015 and 2016: Long-Term Debt Issuances soared 2025.87% in 2015, then tumbled 442.01% in 2016.
- Over 3 years, Long-Term Debt Issuances stood at $715000.0 in 2014, then jumped by 2025.87% to $15.2 million in 2015, then sank by 442.01% to -$52.0 million in 2016.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered -$52.0 million, $15.2 million, and -$15.2 million for Q4 2016, Q4 2015, and Q2 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -675,522.58 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -51.99 Mn |
| Dec 31, 2016 | -51.99 Mn |
| Dec 31, 2015 | 15.20 Mn |
| Dec 31, 2015 | 15.20 Mn |
| Jun 30, 2015 | -15.20 Mn |
| Jun 30, 2015 | -15.20 Mn |
| Mar 31, 2015 | 21.00 Mn |
| Mar 31, 2015 | 21.00 Mn |
| Dec 31, 2014 | 715,000.00 |
| Dec 31, 2014 | 715,000.00 |